Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implicationsDivij Mathew, Eric Perkey, M. Betina Pampena et al.|Science|2020Cited by 1.7k
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19Laura A. Vella, Justin Kim, Josephine R. Giles et al.|Science Immunology|2021Cited by 206
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic CancerKatelyn T. Byrne, Robert H. Vonderheide|Clinical Cancer Research|2021Cited by 178
Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancerKatie E. Blise, Katelyn T. Byrne|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1